Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2025-12-24 @ 4:51 PM
NCT ID:
NCT03891550
Eligibility Criteria:
Inclusion Criteria:
* Medical staffs and patients on HD, with age 20 years or more at the time of screening, agree to participate the study and provide informed consent.
* A negative serum pregnancy test is required for female subjects (unless permanently sterile or greater than two years post-menopausal)
* Subjects and their partners are considered childbearing potential must agree to use acceptable contraceptive method during treatment till SVR12.
* Ability to participate and willingness to give written informed consent and to comply with the study restrictions.
Exclusion Criteria:
Medical staffs or uremic patients who are seropositive for HCV RNA and have contraindication to or unwilling to receive SOF/VEL, or who failed to prior IFN-free direct antiviral agents (DAA) regimens
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT03891550
Study Brief:
Protocol Section:
NCT03891550